NCT00557518View on ClinicalTrials.gov

Study of Alagebrium in Patients With Insulin-Dependent Type 1 Diabetes and Microalbuminuria

PHASE2TerminatedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

September 30, 2009

Study Completion Date

November 30, 2009

Conditions
Diabetes Mellitus, Type 1Diabetic Nephropathy
Interventions
DRUG

Alagebrium

200 mg bid

DRUG

Placebo

bid

Trial Locations (6)

2050

Royal Prince Alfred Hospital, Camperdown

3004

The Alfred Hospital, Melbourne

3084

Austin Health, Heidelburg

3162

International Diabetes Institute, Caulfield

3220

Dept. of Clinical and Biomedical Science Myers House, Geelong

DK-2820

Steno Diabetes Center, Gentofte Municipality

Sponsors
All Listed Sponsors
collaborator

Juvenile Diabetes Research Foundation

OTHER

lead

Synvista Therapeutics, Inc

INDUSTRY